Akèy › Skleroz Amiotrofik Lateral › Massachusetts › Boston
Etid klinik pou Skleroz Amiotrofik Lateral nan Boston, MA
19 etid pou Skleroz Amiotrofik Lateral ap chèche patisipan nan sit nan ak bò kote Boston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
RAPA-501 Therapy for ALS
Ap rekriteFaz 2/3
- Massachusetts General Hospital, Boston
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
Ap rekriteFaz 3
- Sean M. Healey & AMG Center for ALS, Boston
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Ap rekriteFaz 2
- Dana Farber Cancer Institute, Boston
Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability Study
Ap rekrite
- Beth Israel Deaconess Medical Center, Boston
Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS
Ap rekriteFaz 1/2
- Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital, Boston
Usnoflast Neuromuscular Investigation for Treatment Efficacy in Amyotrophic Lateral Sclerosis
Ap rekriteFaz 2
- Zydus US010, Boston
ASSESS ALL ALS Study
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Massachusetts General Brigham, Boston
PREVENT ALL ALS Study
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Massachusetts General Brigham, Boston
Study of COYA 302 for the Treatment of ALS
Ap rekriteFaz 2/3
- Massachusetts General Hospital, Boston
ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Massachusetts General Hospital, Boston
Tofersen in Non-SOD1 ALS
Ap rekriteFaz 2
- Massachusetts General Hospital, Boston
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia
Ap rekrite
- Massachusetts General Hospital, Boston
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
Ap rekrite
- Massachusetts General Hospital, Boston
EIM Via the Myolex mScan as an ALS Biomarker
Ap rekriteEtid obsèvasyon
- Massachusetts General Hospital, Boston
- Beth Israel Deaconess Medical Center, Boston
Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI)
Ap rekrite
- Massachusetts General Hospital, Boston
AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis
Ap rekriteFaz 1
- Massachusetts General Hospital, Healey & AMG Center for ALS, Boston
A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Participants With Superoxide Dismutase 1 (SOD-1) Amyotrophic Lateral Sclerosis (ALS)
Ap rekriteEtid obsèvasyon
- Mass General Hospital -MGH, Boston
Intermuscular Coherence as a Biomarker for ALS
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Massachusetts General Hospital, Boston
Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Massachusetts General Hospital, Boston
Etid Skleroz Amiotrofik Lateral nan lòt vil
- Philadelphia, PA14 etid
- Jacksonville, FL13 etid
- Baltimore, MD13 etid
- New York City, NY11 etid
- San Francisco, CA10 etid
- Chicago, IL10 etid
- San Diego, CA10 etid
- St. Louis, MO9 etid
- Dallas, TX8 etid
- Phoenix, AZ8 etid
- Atlanta, GA8 etid
- Washington, DC7 etid
Lòt etid nan Boston
- Kansè nan tete112 etid
- Kansè Poumon ki pa ti selil90 etid
- Kansè (tout kalite)85 etid
- Kansè Metastatik63 etid
- Kansè kolorektal63 etid
- Kansè poumon62 etid
- Kansè ovè61 etid
- Kansè pwostat59 etid
- Depresyon52 etid
- Kansè Endomèt50 etid
- Ensifizyans kadyak44 etid
- Leksemi mieloïd egi44 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.